Valores de linfocitos T Activos en pacientes con Bocio Tóxico difuso (Graves-Basedow)
PDF

Palabras clave

linfocitos T Activos
bocio tóxico difuso
Graves-Basedow

Cómo citar

Uriarte, A., & Alavez, E. (2018). Valores de linfocitos T Activos en pacientes con Bocio Tóxico difuso (Graves-Basedow). Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, -12(1), 28–32. https://doi.org/10.53853/encr.-12.1.179

Resumen

Los valores de linfocitos T de alta afinidad por los glóbulos rojos de carnero (linfocitos T activos) están significativamente disminuídos en pacientes con Bocio Tóxico Difuso (BTD), lo que sugiere una evidencia más, de alteración de la inmunidad mediada por células en esta enfermedad.

No existen diferencias en los valores de linfocitos T totales y linfocitos B entre personas normales y con BTD.

SUMMARY

Active T - lymphocyte values in patients with diffuse toxic goiter (Graves - Besedow)

The values of T - lymphocyte with high affinity for sheep red blood ells (active T-lymphocytes) are significantly decreased in patients with Difusse Toxic Goiter (DTG), suggesting once more the alterations in all - mediated in munity in this disease.

There are no differences between values of total T - lymphocytes and B - lymphocytes among normal person and those with DTB.

 

 

https://doi.org/10.53853/encr.-12.1.179
PDF

Citas

1. Mori. T. and Kriss, J.P. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J. Clin. Endocr. Metab. 33; 668, 1971.
2. McKenzie, J. M.: Humoral factors in the pathogenesis of Graves´ disease. Physiological Reviews, 48. 252, 1968
3. Lamki, L. Row, V.V. Wolpe, R.: Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration inhibition factor (MIF) J. Clin. Endocrinol Meso. 36:358, 1973.
4. Wolpé, R., Fardd, N.R., Won Westar, C., Row, V.V.: The pathogenesis of Graves' disease and Hashimoto thyroiditis. Clin. Endocrinol. 3: 239, 1974.
5. Wybran J. and Fudenberg, H.H.: Thymus derived rosette - forming cells in various human disease states.: Cancer, lymphoma, bacterial and other disease. J. Clin. Invest. 52; 1026, 1973
6. Wybran, J. Can, M.C., and Fudenberg, H.H. The human rosette forming cell as a marker of a population of thymus derived cells. J. Clin. Invest. 51: 2537, 1972.
7. Meziharadsky, J. and Babusikova, O. Disminished in vitro effect of phyrohaemoaglutinin of lymphocytes of rats bearing singenic tumours, Neoplasma. 20, 4, 1973.
8. Urbanak, S.J., Penhake, W.J., Irvine, W.J. Peripheral blood T and B lymphocytes in patients with thyrotoxicosis and Hashimoto's thyroiditis and in normal subjects: a comparison of lymphocytes separation methods. Clin. Exp. Immunol. 18: 449, 1974.
9. Calder E.A. Urbaniak, S.J., Irvine, W.J., and James, K.: The effect of anti-alpha 2 macroglobulin on K cell cytolisis and T and B cells rosette formation. Clin. Exp. Immunol. 22, 112. 1975.
10. Siegels Diseño experimental no paramétrico. Pag. 64, 1970.
11. Faraid. N. R. Munro, R.E. Row. V.V. Volpé, R. Peripheral thymus dependent (T) lymphocytes in Graves' disease and Hashimoto' thyroiditis. N. Engl. J. Med. 288: 1313, 1973.
12. Aoki, N. Wakisaki. G. Nagata.I.: increase of T cells in Graves' disease. Lancet. 2:49, 1973. 13.
13. Wara, D.W., Reiter, E.D., Ammans, J.A.: T cell rosettes in thyrotoxic Graves' disease, N. Engl. J. Med. 289; 1145, 1973.
14. Volpé. R. Row. V.V., Proportion of E rosettes normal in Graves' and Hashimoto's diseases: a retraccion, N. Engl. J. Med. 293. 44, 1975.
15. Felsburg. P.J. Edelman, R. and Gilman. R.H.: The active E rosette test: Correlation with delayed cutaneous hypersensitivity. J. Immunol. 116. 1110, 1976.
Los autores deben declarar revisión, validación y aprobación para publicación del manuscrito, además de la cesión de los derechos de publicación, mediante un documento que debe ser enviado antes de la aparición del escrito.  Puede consultar una copia del documento aquí

Descargas

Los datos de descargas todavía no están disponibles.